Reifenstein syndrome is one of a group of diseases in which the body is unable to respond appropriately to the male sex hormones (androgens), which include testosterone. The syndrome is passed down through families (inherited) and causes underdevelopment of the male reproductive tract.
In this syndrome, a problem with a gene causes cells to be less responsive to male hormones called androgens. It is also called Partial Androgen Insensitivity Syndrome. As a male baby grows in the womb, male hormones (androgens) are made. As a result, male sexual organs develop. However, sometimes there is a change in the gene that helps make a protein (receptor) that tells the body how to use androgen properly. If androgen cannot be processed normally because of a defect in this protein, problems with the development of the male sex organs occur. At birth, this may result in confusion over the sex of the baby due to ambiguous genitalia. The disease is inherited in an X-linked recessive manner, which means that women are not affected but may carry the gene. Males who inherit the gene from their mothers will have the condition. There is a 50% chance that a male child of a mother with the gene will be affected. Family history is important in determining risk factors. The syndrome is estimated to affect 1 in 99,000 people.
Symptoms include:
The doctor will perform a physical exam. The male may have: Tests may include:
Early and continuous testosterone treatment may improve the chance that a boy will grow up to be fertile.
|
|
Reviewer Info: Brian Kirmse, MD, Mount Sinai School of Medicine, Department of Human Genetics, New York, NY. Review provided by VeriMed Healthcare Network.; ADAM Health Illustrated Encyclopedia, 12/11/2006 |